Vasoactive Intestinal Polypeptide (VIP) in Asthmaa
- 1 July 1991
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 629 (1) , 305-318
- https://doi.org/10.1111/j.1749-6632.1991.tb37985.x
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Characterization of VIP- and helodermin-preferring receptors on human small cell lung carcinoma cell linesPeptides, 1990
- A New Approach to the Treatment of AsthmaNew England Journal of Medicine, 1989
- Absence of Immunoreactive Vasoactive Intestinal Polypeptide in Tissue from the Lungs of Patients with AsthmaNew England Journal of Medicine, 1989
- Molecular characteristics and evidence for internalization of vasoactive‐intestinal‐peptide (VIP) receptors in the tumoral rat‐pancreatic acinar cell line AR 4‐2 JEuropean Journal of Biochemistry, 1988
- Cycle of the vasoactive intestinal peptide and its binding site in a human adenocarcinoma cell line (HT 29)European Journal of Biochemistry, 1986
- Characterisation of a high-affinity VIP receptor in human lung parenchymaFEBS Letters, 1986
- Nerve fibres containing peptide histidine isoleucine (PHI) in the respiratory tractEuropean Archives of Oto-Rhino-Laryngology, 1985
- Effect of vasoactive intestinal peptide on vagally mediated tracheal pouch relaxationRespiration Physiology, 1984
- Vasoactive Intestinal Peptide: A Possible Transmitter of Nonadrenergic Relaxation of Guinea Pig AirwaysScience, 1980
- Bronchodilatation: Noncholinergic, Nonadrenergic Mediation Demonstrated in Vivo in the CatScience, 1980